Health ❯Healthcare ❯Patient Care

Chronic Illness Management

Support Systems Resource Allocation GvHD Patient Population Injection Therapy Motor Fluctuations Cognitive Decline Alzheimer's Disease Treatment Lupus Treatment Quadriparesis Recovery Multiple Sclerosis Treatment

FDA Clears At-Home Leqembi Injection for Weekly Maintenance in Early Alzheimer’s

The new 360 mg weekly autoinjector lets eligible patients continue therapy after 18 months of infusions with comparable benefits and safety.

FDA Approves First Implanted Vagus Nerve Stimulator for Rheumatoid Arthritis

Fiona Phillips’s Memoir Highlights Gaps in Dementia Support for Younger Patients

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

NICE Approves Alyftrek, Extending Modulator Treatment to 95% of Cystic Fibrosis Patients

UK Administers First Teplizumab Immunotherapy to Adult Type 1 Diabetes Patient

Häppi Pilot Debuts in Rhineland-Palatinate to Transform Rural GP Care

Ongoing UK Trial Finds Avantect Test 68% Accurate at Detecting Early Pancreatic Cancer

NICE Poised to Reject NHS Coverage for Breakthrough Alzheimer’s Drugs

Spain Unveils €10 Million Bridge Plan for 24-Hour ALS Patient Care

Gene Therapy Restores Immune Function in Children with Rare Disorder

Actor Eric Dane Reveals ALS Diagnosis and Plans to Continue Acting

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

Study Unveils Human Heart's Potential for Regeneration

UK Government Proposes £889M Plan to Revitalize GP Services

Groundbreaking Lupus Treatment Trial Offers Hope for Drug-Free Remission

FDA Approves Vyalev for Advanced Parkinson's Disease Treatment

Weight-Loss Drugs Reshape Health and Consumer Markets